Literature DB >> 29575423

Cytological preparations for molecular analysis: A review of technical procedures, advantages and limitations for referring samples for testing.

G da Cunha Santos1,2, M A Saieg3,4, G Troncone5, P Zeppa6.   

Abstract

Minimally invasive procedures such as endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) must yield not only good quality and quantity of material for morphological assessment, but also an adequate sample for analysis of molecular markers to guide patients to appropriate targeted therapies. In this context, cytopathologists worldwide should be familiar with minimum requirements for refereeing cytological samples for testing. The present manuscript is a review with comprehensive description of the content of the workshop entitled Cytological preparations for molecular analysis: pre-analytical issues for EBUS TBNA, presented at the 40th European Congress of Cytopathology in Liverpool, UK. The present review emphasises the advantages and limitations of different types of cytology substrates used for molecular analysis such as archival smears, liquid-based preparations, archival cytospin preparations and FTA (Flinders Technology Associates) cards, as well as their technical requirements/features. These various types of cytological specimens can be successfully used for an extensive array of molecular studies, but the quality and quantity of extracted nucleic acids rely directly on adequate pre-analytical assessment of those samples. In this setting, cytopathologists must not only be familiar with the different types of specimens and associated technical procedures, but also correctly handle the material provided by minimally invasive procedures, ensuring that there is sufficient amount of material for a precise diagnosis and correct management of the patient through personalised care.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  DNA; FNA; FTA cards; cell block; cytology; cytospin preparation; endobronchial ultrasound guided transbronchial needle aspiration; molecular cytopathology; smears

Mesh:

Year:  2018        PMID: 29575423     DOI: 10.1111/cyt.12534

Source DB:  PubMed          Journal:  Cytopathology        ISSN: 0956-5507            Impact factor:   2.073


  3 in total

Review 1.  Molecular biomarker testing for non-small cell lung cancer: consensus statement of the Korean Cardiopulmonary Pathology Study Group.

Authors:  Sunhee Chang; Hyo Sup Shim; Tae Jung Kim; Yoon-La Choi; Wan Seop Kim; Dong Hoon Shin; Lucia Kim; Heae Surng Park; Geon Kook Lee; Chang Hun Lee
Journal:  J Pathol Transl Med       Date:  2021-05-11

2.  Evaluation of Cytologic Sample Preparations for Compatibility With Nucleic Acid Analysis.

Authors:  Laure Sorber; Bart Claes; Karen Zwaenepoel; Bieke Van Dorst; Koen De Winne; Els Fransen; Reinier Wener; Therese Lapperre; Filip Lardon; Patrick Pauwels
Journal:  Am J Clin Pathol       Date:  2022-02-03       Impact factor: 2.493

3.  Yield and costs of molecular diagnostics on thyroid cytology slides in the Netherlands, adapting the Bethesda classification.

Authors:  Mehtap Derya Aydemirli; Marieke Snel; Tom van Wezel; Dina Ruano; Christianne M H Obbink; Wilbert B van den Hout; Abbey Schepers; Hans Morreau
Journal:  Endocrinol Diabetes Metab       Date:  2021-09-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.